Profile
Edward Kim is currently Chief Medical Officer at Orexo AB since 2022.
Formerly, Dr. Kim was Vice President & Head-Medical Affairs at Biohaven Pharmaceutical Holding Co. Ltd. from 2020 to 2022 and Vice Chairman-Clinical Services at Robert Wood Johnson Medical School.
Education includes an undergraduate degree from Harvard University, a doctorate from Sidney Kimmel Medical College, and an MBA from the University of Massachusetts.
Edward Kim active positions
| Companies | Position | Start |
|---|---|---|
| OREXO AB | Chief Tech/Sci/R&D Officer | 26/10/2022 |
Former positions of Edward Kim
| Companies | Position | End |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | 01/10/2022 |
Robert Wood Johnson Medical School
Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Edward Kim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orexo AB
Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Medical School
Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sidney Kimmel Medical College
Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
- Stock Market
- Insiders
- Edward Kim
















